From the category archives:

Bovernment

Tweet- From LexisNexis® Mealey’s™ Daily Legal News. The Food and Drug Administration on Feb. 13 notified Hospira Inc. that the agency has expanded its prohibition against the importation of the company’s Symbiq infusion pumps to include its Plum, GemStar and LifeCare PCA infusion pumps made in Hospira’s Costa Rica manufacturing plant. Hospira reported the expanded […]

{ 0 comments }